Marko I. Klisovic

1.3k total citations
11 papers, 832 citations indexed

About

Marko I. Klisovic is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Marko I. Klisovic has authored 11 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Hematology and 2 papers in Oncology. Recurrent topics in Marko I. Klisovic's work include Acute Myeloid Leukemia Research (7 papers), Histone Deacetylase Inhibitors Research (5 papers) and Epigenetics and DNA Methylation (3 papers). Marko I. Klisovic is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Histone Deacetylase Inhibitors Research (5 papers) and Epigenetics and DNA Methylation (3 papers). Marko I. Klisovic collaborates with scholars based in United States and Saudi Arabia. Marko I. Klisovic's co-authors include Guido Marcucci, John C. Byrd, Michael R. Grever, Susan P. Whitman, Shujun Liu, Mark R. Parthun, Christoph Plass, Clara D. Bloomfield, Laura J. Rush and Martin Guimond and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Marko I. Klisovic

11 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marko I. Klisovic United States	10	681	376	98	93	89	11	832
Joanne I. Hsu United States	7	346 0.5×	255 0.7×	87 0.9×	143 1.5×	45 0.5×	15	630
Stephan Metzelder Germany	11	276 0.4×	420 1.1×	143 1.5×	159 1.7×	78 0.9×	20	648
Jennifer L. Rocnik United States	9	273 0.4×	357 0.9×	100 1.0×	142 1.5×	75 0.8×	12	553
Terry J. Gaymes United Kingdom	13	585 0.9×	280 0.7×	265 2.7×	105 1.1×	80 0.9×	24	800
N. Roubi France	6	558 0.8×	377 1.0×	232 2.4×	116 1.2×	83 0.9×	8	809
Victoria Grandage United Kingdom	9	492 0.7×	472 1.3×	177 1.8×	147 1.6×	264 3.0×	16	926
P. Papadopoulos United Kingdom	7	206 0.3×	233 0.6×	66 0.7×	90 1.0×	70 0.8×	10	426
Marcelo J. Murai United States	9	596 0.9×	224 0.6×	91 0.9×	46 0.5×	30 0.3×	17	769
John Anto Pulikkan United States	14	692 1.0×	337 0.9×	102 1.0×	60 0.6×	43 0.5×	21	868
Pui K. Chan United States	12	629 0.9×	156 0.4×	157 1.6×	49 0.5×	39 0.4×	18	756

Countries citing papers authored by Marko I. Klisovic

Since Specialization

Citations

This map shows the geographic impact of Marko I. Klisovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko I. Klisovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko I. Klisovic more than expected).

Fields of papers citing papers by Marko I. Klisovic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marko I. Klisovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko I. Klisovic. The network helps show where Marko I. Klisovic may publish in the future.

Co-authorship network of co-authors of Marko I. Klisovic

This figure shows the co-authorship network connecting the top 25 collaborators of Marko I. Klisovic. A scholar is included among the top collaborators of Marko I. Klisovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marko I. Klisovic. Marko I. Klisovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Klisovic, Rebecca B., Wendy Stock, Spero R. Cataland, et al.. (2008). A Phase I Biological Study of MG98, an Oligodeoxynucleotide Antisense to DNA Methyltransferase 1, in Patients with High-Risk Myelodysplasia and Acute Myeloid Leukemia. Clinical Cancer Research. 14(8). 2444–2449. 64 indexed citations

Klisovic, Dino D., et al.. (2005). Depsipeptide inhibits migration of primary and metastatic uveal melanoma cell lines in vitro: a potential strategy for uveal melanoma. Melanoma Research. 15(3). 147–153. 28 indexed citations

Marcucci, Guido, Wendy Stock, Guowei Dai, et al.. (2005). Phase I Study of Oblimersen Sodium, an Antisense to Bcl-2, in Untreated Older Patients With Acute Myeloid Leukemia: Pharmacokinetics, Pharmacodynamics, and Clinical Activity. Journal of Clinical Oncology. 23(15). 3404–3411. 112 indexed citations

Whitman, Susan P., Shujun Liu, Tamara Vukosavljevic, et al.. (2005). The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy. Blood. 106(1). 345–352. 97 indexed citations

Chan, Kenneth K., Shujun Liu, Dale G. Hoyt, et al.. (2005). Cellular Uptake and Intracellular Levels of the Bcl-2 Antisense G3139 in Cultured Cells and Treated Patients with Acute Myeloid Leukemia. Clinical Cancer Research. 11(8). 2998–3008. 33 indexed citations

Liu, Shujun, Tiansheng Shen, Lenguyen Huynh, et al.. (2005). Interplay of RUNX1/MTG8 and DNA Methyltransferase 1 in Acute Myeloid Leukemia. Cancer Research. 65(4). 1277–1284. 115 indexed citations

Liu, Shujun, Marko I. Klisovic, Tianyu Shen, et al.. (2004). Promotes Gene Expression by Disrupting the DNA Binding of the AML1/ETO and HDAC1 Repressor Complex.. Blood. 104(11). 4386–4386. 1 indexed citations

Klisovic, Dino D., Steven E. Katz, Marko I. Klisovic, et al.. (2003). Depsipeptide (FR901228) Inhibits Proliferation and Induces Apoptosis in Primary and Metastatic Human Uveal Melanoma Cell Lines. Investigative Ophthalmology & Visual Science. 44(6). 2390–2390. 49 indexed citations

Klisovic, Marko I., Mark R. Parthun, Martin Guimond, et al.. (2003). Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells. Leukemia. 17(2). 350–358. 115 indexed citations

10.

Zhang, Liwen, Michael A. Freitas, Joseph Wickham, et al.. (2003). Differential expression of histone post-translational modifications in acute myeloid and chronic lymphocytic leukemia determined by high-pressure liquid chromatography and mass spectrometry. Journal of the American Society for Mass Spectrometry. 15(1). 77–86. 52 indexed citations

11.

Marcucci, Guido, John C. Byrd, Guowei Dai, et al.. (2002). Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia. Blood. 101(2). 425–432. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact